A Prospective Evaluation of the Combined Helical Tomotherapy and Chemotherapy in Pediatric Patients with Unresectable Rhabdomyosarcoma of the Temporal Bone
- 159 Downloads
We determined the efficacy of combined helical tomotherapy (HT) and chemotherapy in primary/recurrent unresectable rhabdomyosarcoma (RMS) of temporal bone. For this purpose, 9 patients (7 males/2 females), aged 4–9 (average: 6.89) years, with unresectable embryonal RMS of the temporal bone were treated at our hospital. The tumors had either invaded the carotid artery in the cavernous sinus (7/9) or both the cavernous sinus and the skull base foramen (2/9); 7 patients had primary and 2 had recurrent RMS. All patients underwent 2 cycles of induction chemotherapy with VIE (vincristine, ifosfamide, and etoposide), followed by concurrent HT (50–70 Gy) and chemotherapy with VE (vincristine and etoposide for 2 cycles), and 11 cycles of adjuvant chemotherapy with VIE. As a result, all patients achieved complete response, and the 2-year tumor-free survival rate was 100 %. During a follow-up of 3–51 months, all 9 patients were alive. We, therefore, conclude that the induction chemotherapy, adjuvant chemotherapy with VIE and concurrent HT and chemotherapy with VE regimen is effective in treating unresectable embryonal RMS of the temporal bone. The combined modality treatment may achieve the best chance of cure for these patients, thereby changing the therapeutic strategy from palliative to possibly curative.
KeywordsRhabdomyosarcoma of temporal bone Unresectable Helical tomotherapy Chemotherapy with VIE
This work was supported by grants from National Natural Science Foundation (81072195) and Beijing Municipal Science & Technology Commission (Z121107001012042).
Conflict of interest
The authors have declared no conflict of interest.
- 1.Kuhel, W. I., Hume, C. R., & Selesnick, S. H. (1996). Cancer of the external auditory canal and temporal bone. Otolaryngologic Clinics of Noth America, 29, 827–852.Google Scholar
- 2.Evans, R. W. (1966). Histological appearance of tumors (2nd ed., p. 56). Edinburgh: Livingstone.Google Scholar
- 3.Willis, R. A. (1967). Pathology of tumours (4th ed., p. 758). London: Butterworth.Google Scholar
- 4.Russell, D. S., & Rubebstein, L. J. (1959). The pathology of tumours of the nervous system (p. 215). London: Arnold.Google Scholar
- 12.Sbeity, S., Abella, A., Arcand, P., Quintal, M. C., & Saliba, I. (2007). Temporal bone rhabdomyosarcoma in children. Otorhinolaryngology, 71, 807–814.Google Scholar
- 13.Viswanatha, B. (2007). Embryonal rhabdomyosarcoma of the temporal bone. Ear, Nose, and Throat Journal, 86(218), 220–222.Google Scholar
- 14.Abbas, A., & Awan, S. (2005). Rhabdomyosarcoma of the middle ear and mastoid: a case report and review of the literature. Ear Nose Throat Journal, 84, 780, 782, 784.Google Scholar